Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere | 5 | 2025 | 276 | 1.660 |
Why?
|
| Cellular Senescence | 6 | 2024 | 190 | 1.040 |
Why?
|
| DNA Replication | 2 | 2025 | 239 | 0.900 |
Why?
|
| Autophagy | 3 | 2023 | 286 | 0.750 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 20 | 0.610 |
Why?
|
| Carcinogenesis | 2 | 2022 | 216 | 0.570 |
Why?
|
| DNA Breaks, Single-Stranded | 2 | 2022 | 5 | 0.540 |
Why?
|
| Mitochondria | 1 | 2023 | 951 | 0.500 |
Why?
|
| DNA Repair | 4 | 2022 | 231 | 0.470 |
Why?
|
| Epithelial Cells | 2 | 2019 | 1100 | 0.410 |
Why?
|
| Aging | 1 | 2023 | 1859 | 0.400 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2472 | 0.350 |
Why?
|
| Signal Transduction | 1 | 2023 | 5068 | 0.310 |
Why?
|
| Keratinocytes | 2 | 2024 | 249 | 0.300 |
Why?
|
| DNA Damage | 4 | 2022 | 422 | 0.300 |
Why?
|
| Immunity, Innate | 2 | 2023 | 826 | 0.270 |
Why?
|
| Neoplasms | 3 | 2023 | 2712 | 0.250 |
Why?
|
| Telomeric Repeat Binding Protein 1 | 1 | 2025 | 5 | 0.240 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2024 | 8 | 0.230 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2017 | 66 | 0.220 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2017 | 43 | 0.220 |
Why?
|
| Dinoprostone | 1 | 2024 | 192 | 0.210 |
Why?
|
| Cyclooxygenase 2 | 1 | 2024 | 176 | 0.210 |
Why?
|
| Telomere Shortening | 1 | 2022 | 20 | 0.190 |
Why?
|
| Heterochromatin | 1 | 2022 | 53 | 0.190 |
Why?
|
| Centromere | 1 | 2022 | 59 | 0.180 |
Why?
|
| Interferons | 1 | 2023 | 203 | 0.180 |
Why?
|
| Fibroblasts | 2 | 2019 | 1002 | 0.170 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 114 | 0.170 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 172 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 524 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2022 | 329 | 0.160 |
Why?
|
| Nucleotidyltransferases | 1 | 2019 | 27 | 0.150 |
Why?
|
| Chromatin | 2 | 2022 | 517 | 0.150 |
Why?
|
| Nuclear Envelope | 1 | 2019 | 40 | 0.150 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 97 | 0.140 |
Why?
|
| Sumoylation | 2 | 2017 | 15 | 0.130 |
Why?
|
| Cell Line | 2 | 2022 | 2865 | 0.130 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2016 | 13 | 0.120 |
Why?
|
| DNA | 1 | 2023 | 1448 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2016 | 98 | 0.120 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2016 | 50 | 0.120 |
Why?
|
| Inflammation | 1 | 2023 | 2847 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1154 | 0.090 |
Why?
|
| Humans | 10 | 2025 | 138102 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1477 | 0.070 |
Why?
|
| Apoptosis | 1 | 2017 | 2555 | 0.070 |
Why?
|
| DNA Primase | 1 | 2025 | 47 | 0.060 |
Why?
|
| Sirtuin 1 | 2 | 2017 | 30 | 0.060 |
Why?
|
| Etoposide | 2 | 2017 | 160 | 0.060 |
Why?
|
| Histone Deacetylases | 2 | 2017 | 211 | 0.050 |
Why?
|
| Telomerase | 1 | 2025 | 248 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2024 | 4160 | 0.050 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2022 | 8 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2017 | 395 | 0.050 |
Why?
|
| Repressor Proteins | 2 | 2017 | 423 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 635 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2022 | 635 | 0.040 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2017 | 29 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 65 | 0.030 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 195 | 0.030 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2013 | 26 | 0.020 |
Why?
|
| COS Cells | 1 | 2013 | 183 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 352 | 0.020 |
Why?
|
| Acetylation | 1 | 2013 | 245 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1237 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 626 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 191 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 1598 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 679 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 2232 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3404 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 1322 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 37151 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2125 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 17769 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 3994 | 0.010 |
Why?
|
| Male | 1 | 2014 | 67984 | 0.000 |
Why?
|
| Female | 1 | 2014 | 73648 | 0.000 |
Why?
|